Prescreening is an early fit check. Eligibility is confirmed later by the authorized study team based on the protocol and required review steps.
In this guide
Key points
- Prescreening helps identify whether a study may be worth discussing.
- Eligibility is confirmed only after authorized review and any required screening steps.
- Applying to a study does not mean a patient is enrolled.
Prescreening is an early signal
Prescreening usually asks a focused set of questions about diagnosis history, age range, location, current treatments, availability, or study-specific factors.
The goal is to help the study team decide whether follow-up makes sense. It is not a final study decision.
Eligibility is protocol-based
Clinical trial eligibility depends on inclusion and exclusion criteria in the study protocol. The authorized research team may need more details than a short prescreen can collect.
Some studies require records, lab results, screening visits, medication review, investigator assessment, or sponsor-defined checks before eligibility can be confirmed.
What patients should expect
After applying, patients may receive a message, phone call, document request, or appointment invitation depending on the study team's process and consent preferences.
The safest expectation is simple: prescreening starts the conversation, and final eligibility comes later.
Why the distinction matters
The difference between prescreening and eligibility protects patients from assuming too much too early. A short questionnaire can help route follow-up, but it cannot replace protocol review, required screening, or the patient's own decision after learning more.
It also helps study teams communicate clearly. Patients should know when they are sharing early fit information, when a screening step is being planned, and when a final eligibility decision has not yet been made.
Common questions
Does a prescreen result confirm that I can join?
No. Prescreening provides information for study-team review. The authorized team makes the final eligibility and enrollment decisions.
Sources and editorial notes
Published .
This guide explains recruitment work and questions to discuss with your team.
This information is educational. Your study team makes medical, eligibility, and enrollment decisions.
Study information
Have questions about taking part?
Review study information and ask the study team about visits, screening, and what happens next.
Keep reading
What happens after you apply for a clinical trial?
A plain-language guide to what happens after a clinical trial application, including coordinator review, possible follow-up, screening, and enrollment decisions.
How clinical trial prescreening works before a study team follows up
A plain-language guide to clinical trial prescreening, what patients may be asked, and how study teams use early fit signals before final eligibility review.
